Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

420129 JNK Inhibitor V - CAS 345987-15-7 - Calbiochem

The JNK Inhibitor V, also referenced under CAS 345987-15-7, controls the biological activity of JNK. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: SAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245

Primary Target: hJNK 1, hJNK 2, hJNK 3
420129
Purchase on Sigma-Aldrich

概述

Replacement Information

重要规格表

CAS #Empirical Formula
345987-15-7C₂₀H₁₆N₆S

Products

产品目录编号包装 数量 / 包装
420129-5MGCN 塑胶安瓿;塑胶针药瓶 5 mg
Description
OverviewA cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration.
Catalogue Number420129
Brand Family Calbiochem®
SynonymsSAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245
References
ReferencesGaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.
Product Information
CAS number345987-15-7
ATP CompetitiveY
FormYellow solid
Hill FormulaC₂₀H₁₆N₆S
Chemical formulaC₂₀H₁₆N₆S
Hygroscopic Hygroscopic
ReversibleY
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Application CommentsSoluble in DMSO, aliquot & store at -20*C; stable for 3 months
Biological Information
Primary TargethJNK 1, hJNK 2, hJNK 3
Primary Target IC<sub>50</sub>150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively
Purity≥95% by HPLC (sum of two isomers)
Physicochemical Information
Cell permeableY
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Harmful
Storage -20°C
Protect from Light Protect from light
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
420129-5MGCN 04055977188073

Documentation

JNK Inhibitor V - CAS 345987-15-7 - Calbiochem MSDS

职位

物料安全数据表 (MSDS) 

JNK Inhibitor V - CAS 345987-15-7 - Calbiochem 分析证书

标题批号
420129

参考

参考信息概述
Gaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.
数据表

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision04-January-2010 RFH
SynonymsSAPK Inhibitor V, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile, AS601245
DescriptionA cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration.
FormYellow solid
Intert gas (Yes/No) Packaged under inert gas
CAS number345987-15-7
Chemical formulaC₂₀H₁₆N₆S
Structure formulaStructure formula
Purity≥95% by HPLC (sum of two isomers)
SolubilityDMSO (10 mg/ml)
CommentsSoluble in DMSO, aliquot & store at -20*C; stable for 3 months
Storage Protect from light
-20°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Harmful
ReferencesGaillard, P., et al. 2005. J. Med. Chem. 48, 4596.
Carboni, S., et al. 2005. J. Neurochem. 92, 1054.
Ferrandi, C., et al. 2004. Br. J. Pharmacol. 142, 953.
Carboni, S., et al. 2004. J. Pharm. Exp. Ther. 310, 25.